Asbestos, asbestosis, and cancer: The Helsinki criteria for diagnosis and attribution. Critical need for revision of the 2014 update

The Helsinki criteria for diagnosis and attribution. Critical need for revision of the 2014 update

Xaver Baur, Hans Joachim Woitowitz, Lygia T. Budnik, David Egilman, Christine Oliver, Arthur Frank, Colin L. Soskolne, Philip J. Landrigan, Richard A. Lemen

    Research output: Contribution to journalComment/debate

    5 Citations (Scopus)

    Abstract

    Asbestos-related diseases (ARDs) are responsible for a global pandemic. The cancer component of this pandemic recently peaked in many Western countries and its rate of increase is now in decline. This decline is consequent to the introduction several decades ago both of policy interventions and asbestos bans. However, the pandemic continues to increase today in many emerging economies owing to the lax or total absence of restrictions on asbestos importation and use. It is estimated that the asbestos cancer pandemic currently causes 194 000 premature deaths and the loss of nearly 3.4 million disability-adjusted life-years (DALYs) annually, and accounts for almost two-thirds of the burden of all disease worldwide caused by occupational carcinogens.1 More than 10 million lives will have been lost from asbestos-related cancers alone before asbestos is banned worldwide and exposures end.2 Lin et al have estimated that the total number of asbestos-related deaths (including asbestosis cases) is at least double this number.3 Public health interventions at the highest policy levels are needed if the global pandemic of ARDs is to be curtailed.
    Original languageEnglish
    Pages (from-to)411-421
    Number of pages11
    JournalAmerican Journal of Industrial Medicine
    Volume60
    Issue number5
    DOIs
    Publication statusPublished - May 2017

    Fingerprint

    Asbestosis
    Asbestos
    Pandemics
    Neoplasms
    Premature Mortality
    Quality-Adjusted Life Years
    Public Health

    Cite this

    Baur, Xaver ; Woitowitz, Hans Joachim ; Budnik, Lygia T. ; Egilman, David ; Oliver, Christine ; Frank, Arthur ; Soskolne, Colin L. ; Landrigan, Philip J. ; Lemen, Richard A. / Asbestos, asbestosis, and cancer: The Helsinki criteria for diagnosis and attribution. Critical need for revision of the 2014 update : The Helsinki criteria for diagnosis and attribution. Critical need for revision of the 2014 update. In: American Journal of Industrial Medicine. 2017 ; Vol. 60, No. 5. pp. 411-421.
    @article{ad1dbe5bccb04826821c29ab8248d50d,
    title = "Asbestos, asbestosis, and cancer: The Helsinki criteria for diagnosis and attribution. Critical need for revision of the 2014 update: The Helsinki criteria for diagnosis and attribution. Critical need for revision of the 2014 update",
    abstract = "Asbestos-related diseases (ARDs) are responsible for a global pandemic. The cancer component of this pandemic recently peaked in many Western countries and its rate of increase is now in decline. This decline is consequent to the introduction several decades ago both of policy interventions and asbestos bans. However, the pandemic continues to increase today in many emerging economies owing to the lax or total absence of restrictions on asbestos importation and use. It is estimated that the asbestos cancer pandemic currently causes 194 000 premature deaths and the loss of nearly 3.4 million disability-adjusted life-years (DALYs) annually, and accounts for almost two-thirds of the burden of all disease worldwide caused by occupational carcinogens.1 More than 10 million lives will have been lost from asbestos-related cancers alone before asbestos is banned worldwide and exposures end.2 Lin et al have estimated that the total number of asbestos-related deaths (including asbestosis cases) is at least double this number.3 Public health interventions at the highest policy levels are needed if the global pandemic of ARDs is to be curtailed.",
    keywords = "asbestos, diagnostic criteria",
    author = "Xaver Baur and Woitowitz, {Hans Joachim} and Budnik, {Lygia T.} and David Egilman and Christine Oliver and Arthur Frank and Soskolne, {Colin L.} and Landrigan, {Philip J.} and Lemen, {Richard A.}",
    year = "2017",
    month = "5",
    doi = "10.1002/ajim.22709",
    language = "English",
    volume = "60",
    pages = "411--421",
    journal = "American Journal of Industrial Medicine",
    issn = "0271-3586",
    publisher = "Wiley-Liss Inc.",
    number = "5",

    }

    Asbestos, asbestosis, and cancer: The Helsinki criteria for diagnosis and attribution. Critical need for revision of the 2014 update : The Helsinki criteria for diagnosis and attribution. Critical need for revision of the 2014 update. / Baur, Xaver; Woitowitz, Hans Joachim; Budnik, Lygia T.; Egilman, David; Oliver, Christine; Frank, Arthur; Soskolne, Colin L.; Landrigan, Philip J.; Lemen, Richard A.

    In: American Journal of Industrial Medicine, Vol. 60, No. 5, 05.2017, p. 411-421.

    Research output: Contribution to journalComment/debate

    TY - JOUR

    T1 - Asbestos, asbestosis, and cancer: The Helsinki criteria for diagnosis and attribution. Critical need for revision of the 2014 update

    T2 - The Helsinki criteria for diagnosis and attribution. Critical need for revision of the 2014 update

    AU - Baur, Xaver

    AU - Woitowitz, Hans Joachim

    AU - Budnik, Lygia T.

    AU - Egilman, David

    AU - Oliver, Christine

    AU - Frank, Arthur

    AU - Soskolne, Colin L.

    AU - Landrigan, Philip J.

    AU - Lemen, Richard A.

    PY - 2017/5

    Y1 - 2017/5

    N2 - Asbestos-related diseases (ARDs) are responsible for a global pandemic. The cancer component of this pandemic recently peaked in many Western countries and its rate of increase is now in decline. This decline is consequent to the introduction several decades ago both of policy interventions and asbestos bans. However, the pandemic continues to increase today in many emerging economies owing to the lax or total absence of restrictions on asbestos importation and use. It is estimated that the asbestos cancer pandemic currently causes 194 000 premature deaths and the loss of nearly 3.4 million disability-adjusted life-years (DALYs) annually, and accounts for almost two-thirds of the burden of all disease worldwide caused by occupational carcinogens.1 More than 10 million lives will have been lost from asbestos-related cancers alone before asbestos is banned worldwide and exposures end.2 Lin et al have estimated that the total number of asbestos-related deaths (including asbestosis cases) is at least double this number.3 Public health interventions at the highest policy levels are needed if the global pandemic of ARDs is to be curtailed.

    AB - Asbestos-related diseases (ARDs) are responsible for a global pandemic. The cancer component of this pandemic recently peaked in many Western countries and its rate of increase is now in decline. This decline is consequent to the introduction several decades ago both of policy interventions and asbestos bans. However, the pandemic continues to increase today in many emerging economies owing to the lax or total absence of restrictions on asbestos importation and use. It is estimated that the asbestos cancer pandemic currently causes 194 000 premature deaths and the loss of nearly 3.4 million disability-adjusted life-years (DALYs) annually, and accounts for almost two-thirds of the burden of all disease worldwide caused by occupational carcinogens.1 More than 10 million lives will have been lost from asbestos-related cancers alone before asbestos is banned worldwide and exposures end.2 Lin et al have estimated that the total number of asbestos-related deaths (including asbestosis cases) is at least double this number.3 Public health interventions at the highest policy levels are needed if the global pandemic of ARDs is to be curtailed.

    KW - asbestos

    KW - diagnostic criteria

    UR - http://www.scopus.com/inward/record.url?scp=85017534355&partnerID=8YFLogxK

    UR - http://www.mendeley.com/research/asbestos-asbestosis-cancer-helsinki-criteria-diagnosis-attribution-critical-need-revision-2014-updat

    U2 - 10.1002/ajim.22709

    DO - 10.1002/ajim.22709

    M3 - Comment/debate

    VL - 60

    SP - 411

    EP - 421

    JO - American Journal of Industrial Medicine

    JF - American Journal of Industrial Medicine

    SN - 0271-3586

    IS - 5

    ER -